German Pharmaceuticals & Biotech Potentially Undervalued Companies

Spectrum Pharmaceuticals

Market Cap: €209.9m

Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology drug products.

Perrigo

Market Cap: €1.4b

Provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.

Regeneron Pharmaceuticals

Market Cap: €66.7b

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide.

Grand Pharmaceutical Group

Market Cap: €18.2b

An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials.

Indivior Pharmaceuticals

Market Cap: €4.9b

Engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally.

Regeneron Pharmaceuticals

Market Cap: €66.7b

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide.

Prestige Consumer Healthcare

Market Cap: €2.4b

Develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally.

ANI Pharmaceuticals

Market Cap: €1.6b

A biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally.

Trajan Group Holdings

Market Cap: €32.0m

Develops, manufactures, and sells analytical and life science products and devices in Malaysia, Japan, Australia, New Zealand, the United States, Europe, the Middle East, Africa, and India.

Virbac

Market Cap: €2.8b

Manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, the United States, Brazil, and the Pacific.

United Laboratories International Holdings

Market Cap: €17.9b

An investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products.

Bavarian Nordic

Market Cap: €13.3b

Develops, manufactures, and supplies life-saving vaccines.

China Resources Pharmaceutical Group

Market Cap: €29.9b

An investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally.

China Medical System Holdings

Market Cap: €29.3b

An investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China.

Fine Foods & Pharmaceuticals N.T.M

Market Cap: €193.8m

Fine Foods & Pharmaceuticals N.T.M. S.p.A.

Cresco Labs

Market Cap: €436.0m

Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany.

Consun Pharmaceutical Group

Market Cap: €11.3b

Produces and sells pharmaceutical products in Mainland China.

CorMedix

Market Cap: €617.4m

A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.

Laboratorios Farmaceuticos Rovi

Market Cap: €3.0b

Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.

Dermapharm Holding

Market Cap: €2.0b

Manufactures and sells off-patent branded pharmaceutical products in Germany, Italy, France, Austria, Switzerland, Spain, Portugal, the Netherlands, Croatia, Poland, Ukraine, the United States, and China.

High Tide

Market Cap: €268.0m

Engages in the cannabis retail business in Canada, the United States, and internationally.

Vetoquinol

Market Cap: €831.0m

A veterinary pharmaceutical company, engages in designing, developing, and selling of veterinary drugs and non-medicinal products for cattle, pigs, dogs, and cats in Europe, the Americas, and the Asia Pacific region.

Bavarian Nordic

Market Cap: €13.3b

Develops, manufactures, and supplies life-saving vaccines.

Dermapharm Holding

Market Cap: €2.0b

Manufactures and sells off-patent branded pharmaceutical products in Germany, Italy, France, Austria, Switzerland, Spain, Portugal, the Netherlands, Croatia, Poland, Ukraine, the United States, and China.

Goodbody Health

Market Cap: €1.3m

Goodbody Health Inc., a wellness company, provides health and wellness range of products and services in the United Kingdom.

Trulieve Cannabis

Market Cap: €1.6b

Operates as a cannabis retailer in the United States.

Teva Pharmaceutical Industries

Market Cap: €35.9b

Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.

Joincare Pharmaceutical Group IndustryLtd

Market Cap: €17.9b

Joincare Pharmaceutical Group Industry Co.,Ltd.

ACADIA Pharmaceuticals

Market Cap: €4.3b

A biopharmaceutical company, focuses on the development and commercialization of medicines for neurological and rare disease in North America.

HUTCHMED (China)

Market Cap: €1.4b

HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies to treat cancer and immunological diseases in Hong Kong, the United States, and internationally.

TerrAscend

Market Cap: €276.1m

TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States.

Sanofi

Market Cap: €91.4b

Engages in the research, development, manufacture, and marketing of therapeutic solutions.

Theravance Biopharma

Market Cap: €873.8m

A biopharmaceutical company, develops and commercializes medicines in the United States.

CanSino Biologics

Market Cap: €9.5b

Develops, manufactures, and commercializes vaccines in the People’s Republic of China.

Bayer

Market Cap: €45.3b

Operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil.

Gossamer Bio

Market Cap: €66.5m

A clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary hypertension and pulmonary arterial hypertension in the United States.